The federal health experts say that the updated version of Pfizer’s best-selling anti-infection vaccine is safe and effective for infants and toddlers. The new vaccine decreases risk of infection from thirteen varieties of the disease, which annually causes thousands of ear infections, meningitis and pneumonia. The updated version adds protection against six more strains to the seven covered by the current vaccine.
According to the FDA, new strains account for over 60 percent of U.S. pneumococcal cases in children younger than 5.
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
Sign up for a free one-year subscription to EQUITIES Magazine
